Medinotec (MDNC) Net Income towards Common Stockholders (2022 - 2026)
Medinotec (MDNC) posted Net Income towards Common Stockholders of $208499.0 for Q2 2026, down 57.88% on a QoQ basis from $494986.0 in Q1 2026, and down 60.33% year-over-year from $525618.0 in Q2 2025.
Medinotec (MDNC) Net Income towards Common Stockholders (2022 - 2026) Analysis & Trends
Medinotec's Net Income towards Common Stockholders history runs 5 years deep, the most recent figure standing at $208499.0 for Q2 2026.
- Quarterly Net Income towards Common Stockholders fell 60.33% year-over-year to $208499.0 in Q2 2026, while the trailing twelve-month figure through May 2026 was $1.7 million (down 66.88% YoY) and the FY2026 annual result came in at $1.3 million, down 65.44% from the prior year.
- Net Income towards Common Stockholders was $208499.0 for Q2 2026 at Medinotec, down from $494986.0 in the prior quarter.
- Across five years, Net Income towards Common Stockholders topped out at $4.3 million in Q1 2025 and bottomed at -$492371.0 in Q4 2023.
- A 5-year average of $366807.6 and a median of $121872.5 in 2023 frame the typical range for Net Income towards Common Stockholders.
- Annual changes were most pronounced in 2023 — Net Income towards Common Stockholders plunged 2342.02% — and 2024, when it surged 1612.8%.
- Medinotec's Net Income towards Common Stockholders stood at $21961.0 in 2022, then plunged by 2342.02% to -$492371.0 in 2023, then surged by 167.53% to $332486.0 in 2024, then dropped by 26.02% to $245961.0 in 2025, then dropped by 15.23% to $208499.0 in 2026.
- Business Quant data shows MDNC's Net Income towards Common Stockholders at $208499.0 in Q2 2026, $494986.0 in Q1 2026, and $245961.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.95 Bn | 176.66 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 128.83 Bn | 125.95 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 108.81 Bn | 99.59 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 68.39 Bn | 66.94 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 48.28 Bn | 44.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.39 Bn | 27.27 Bn | 750.30 Mn | 199.50 Mn |
| 7 | GE HealthCare Technologies | 28.30 Bn | 26.01 Bn | 1.98 Bn | 411.00 Mn |
| 8 | Smith & Nephew | 26.95 Bn | 26.37 Bn | - | - |
| 9 | Koninklijke Philips | 25.45 Bn | 22.32 Bn | 2.07 Bn | 176.78 Mn |
| 10 | Medinotec | 58.78 Mn | 58.19 Mn | 1.31 Mn | 208,499.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 208,499.00 |
| Feb 28, 2026 | 494,986.00 |
| Nov 30, 2025 | 245,961.00 |
| Aug 31, 2025 | 730,764.00 |
| May 31, 2025 | 525,618.00 |
| Feb 28, 2025 | 4.33 Mn |
| Nov 30, 2024 | 332,486.00 |
| Aug 31, 2024 | -115,928.00 |
| May 31, 2024 | 314,299.00 |
| Feb 29, 2024 | 330,676.00 |
| Nov 30, 2023 | -492,371.00 |
| Aug 31, 2023 | -44,034.00 |
| May 31, 2023 | 18,350.00 |
| Feb 28, 2023 | 35,246.00 |
| Nov 30, 2022 | 21,961.00 |
| Aug 31, 2022 | -219,294.00 |
| May 31, 2022 | 8,528.00 |
| Feb 28, 2022 | -123,999.00 |